Tomorrow Investor

IDEX Metals Reports Integrated 2025 Soil Geochemistry Exploration Results, Freeze Property, Idaho

IDEX Metals Unveils 2025 Exploration Results for Freeze Property | TheNewswire

Vancouver, B.C., March 25, 2026 – TheNewswire – IDEX Metals Corp. (“IDEX” or the “Company”) (TSXV: IDEX; OTCQB: IDXMF) is pleased to report results from its 2025 Freeze Property (“Freeze”, or the “Property”) soil geochemistry program located in Idaho, USA. The program has defined a cohesive, multi-kilometre hydrothermal footprint consistent with an intrusive-centered porphyry copper-molybdenum system. When combined with drill results and geophysical data acquired during the 2025 exploration season, the soil geochemistry completes a multi-disciplinary dataset strongly inferring the presence of a buried intrusive centre beneath the North Breccia-Kismet Corridor. Highlights

This excerpt is quoted from the original release. Read the full announcement on TheNewswire.

Brief Summary

IDEX Metals Corp. is excited to present the results from its 2025 soil geochemistry exploration at the Freeze Property in Idaho, showcasing a substantial hydrothermal system.

  • Identification of a multi-kilometre hydrothermal footprint
  • Support for an intrusive-centered porphyry copper-molybdenum model
  • Integration with drill and geophysical data enhancing exploration efforts
  • Paves the path for future exploration and potential resource identification

Why it matters: This comprehensive dataset may indicate valuable mineralization beneath the surface, attracting investor interest and driving future exploration initiatives.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by TheNewswire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.